Does tumor size improve the accuracy of prognostic predictions in node-negative gastric cancer (pT1-4aN0M0 stage)?

PubWeight™: 0.82‹?›

🔗 View Article (PMC 4086925)

Published in PLoS One on July 08, 2014

Authors

Mu Xu1, Chang-Ming Huang1, Chao-Hui Zheng1, Ping Li1, Jian-Wei Xie1, Jia-Bin Wang1, Jian-Xian Lin1, Jun Lu1

Author Affiliations

1: Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China.

Articles cited by this

Cancer statistics, 2008. CA Cancer J Clin (2008) 86.74

Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer (2011) 16.97

7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol (2010) 5.64

A multicentric Western analysis of prognostic factors in advanced, node-negative gastric cancer patients. Ann Surg (2010) 2.27

Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment. Cell Mol Life Sci (2006) 2.04

The role of stroma in immune recognition and destruction of well-established solid tumors. Curr Opin Immunol (2006) 1.56

Prognostic impact of lymphatic and/or blood vessel invasion in patients with node-negative advanced gastric cancer. Ann Surg Oncol (2002) 1.40

Biologic predictors of survival in node-negative gastric cancer. Ann Surg (2003) 1.37

Recurrence in early gastric cancer. Surgery (1990) 1.28

Factors affecting recurrence in node-negative advanced gastric cancer. J Gastroenterol Hepatol (2009) 1.26

Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas. Cancer Lett (2003) 1.15

Prognostic indicators in node-negative advanced gastric cancer patients. J Surg Oncol (2010) 1.11

Prognostic significance of tumor size in T3 gastric cancer. Ann Surg Oncol (2009) 1.10

Is tumor size a prognostic indicator for gastric carcinoma? Anticancer Res (2003) 1.08

Macroscopic tumor size as a simple prognostic indicator in patients with gastric cancer. Am J Surg (2006) 1.07

Improving outcomes in gastric cancer over 20 years. Gastric Cancer (2004) 1.07

Tumor size: a non-neglectable independent prognostic factor for gastric cancer. J Surg Oncol (2008) 1.04

Clinical impact of metastatic lymph node ratio in advanced gastric cancer. Anticancer Res (2005) 1.02

Risk factors of survival and surgical treatment for advanced gastric cancer with large tumor size. J Gastrointest Surg (2009) 1.02

Clinicopathologic characteristics and outcome indicators in node-negative gastric cancer. J Surg Oncol (2000) 1.02

Survival predictors in patients with node-negative gastric carcinoma. J Gastroenterol Hepatol (2007) 0.99

Recurrent death among early gastric cancer patients: 20-years' experience. Hepatogastroenterology (1994) 0.94

Clinicopathologic evaluation of recurrence in early gastric cancer. Surg Today (1992) 0.91

Prognosis of gastric cancer patients with node-negative metastasis following curative resection: outcomes of the survival and recurrence. Can J Gastroenterol (2008) 0.90

Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence. Hepatogastroenterology (2007) 0.87

Surgical outcome of serosa-negative advanced gastric carcinoma. Anticancer Res (2004) 0.86